GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Debt-to-Asset

Decision Diagnostics (Decision Diagnostics) Debt-to-Asset : 0.61 (As of Sep. 2021)


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Debt-to-Asset?

Decision Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $3.24 Mil. Decision Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $0.00 Mil. Decision Diagnostics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2021 was $5.34 Mil. Decision Diagnostics's debt to asset for the quarter that ended in Sep. 2021 was 0.61.


Decision Diagnostics Debt-to-Asset Historical Data

The historical data trend for Decision Diagnostics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics Debt-to-Asset Chart

Decision Diagnostics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec17 Dec18 Dec19 Dec20
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.40 0.37 0.53 0.50

Decision Diagnostics Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.50 0.53 0.59 0.61

Competitive Comparison of Decision Diagnostics's Debt-to-Asset

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decision Diagnostics's Debt-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's Debt-to-Asset falls into.



Decision Diagnostics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Decision Diagnostics's Debt-to-Asset for the fiscal year that ended in Dec. 2020 is calculated as

Decision Diagnostics's Debt-to-Asset for the quarter that ended in Sep. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decision Diagnostics  (OTCPK:DECN) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Decision Diagnostics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus